Other technical issues covered by the guidelines include:
- Recommendations on use of a powerful new clot-dissolving drug, prasugrel (Effient), as an alternative to clopidogrel (Plavix), commonly prescribed after PCI. The greater ability of the new drug to dissolve clots does carry an added danger of excessive bleeding.
- Use of a wire threaded into the coronary artery to gauge whether build-up of plaque deposits are great enough to warrant PCI.
- Use of aspiration thrombectomy, in which the clot causing a heart attack is sucked out before a stent is implanted.
- Recommendations on use of blood thinners and clot-dissolvers before, during or after PCI.
- Recommendations on the types of X-ray dye used to view the heart arteries during PCI in patients with chronic kidney disease.
Post a Comment